PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-09-09

Date Title Company
09-Sep-2025 New NICE thresholds is good news for ultra-rare disease drugs, says leading biotech, but decisions are still open to interpretation SynaptixBio
09-Sep-2025 Lundbeck sharpens commercial focus in line with strategy, initiates partnering in 27 markets by end-2025 Lundbeck
09-Sep-2025 Almac Group Expands Bioavailability Enhancement Capabilities Almac Group
09-Sep-2025 Cliniphai and Gibson Research Consultancy Partner to Streamline Global COA and eCOA Translation Workflows Cliniphai
09-Sep-2025 Anatomy Warehouse and Erler-Zimmer Announce Exclusive U.S. Partnership to Bring Ethical, High-Fidelity 3D Printed Anatomy Models to Market ACCESS Newswire
09-Sep-2025 LGC Group Opens $100M Organic Chemistry Synthesis Centre of Excellence in Vaughan, Strengthening Canada’s Role in Global Life Sciences Businesswire
09-Sep-2025 aap successfully completes human clinical trial for antibacterial surface technology aap Implantate AG
09-Sep-2025 LGC Group Opens $100M Organic Chemistry Synthesis Centre of Excellence, Expanding Global Capacity for Pharma and Life Sciences Customers Businesswire
09-Sep-2025 Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025 ACCESS Newswire
09-Sep-2025 Logical Biological and Bcell Design Announce Strategic Partnership for Engineered Disease State Materials Logical Biological
09-Sep-2025 Locate Bio Expands RESTORE Clinical Study to the United States Following FDA IDE Approval Locate Bio
09-Sep-2025 Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder Servier
09-Sep-2025 Ireland's Digital Health Reality Check 2025: Trust, Cybersecurity, and Innovation Readiness ACCESS Newswire
09-Sep-2025 TRIMTECH Therapeutics establishes Scientific Advisory Board TRIMTECH Therapeutics
09-Sep-2025 Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis Immunic AG
09-Sep-2025 GEOH Secures Over $30M Growth Investment from Council Capital and Affiliates ACCESS Newswire
09-Sep-2025 West African Leaders Commit to Advance Lassa Fever Vaccine for the Region ACCESS Newswire
09-Sep-2025 FDA Highlights Benzene Presence in Benzoyl Peroxide Acne Products - CLn Acne Cleanser Offers an Alternative ACCESS Newswire
09-Sep-2025 A.forall expands US generics portfolio Businesswire
09-Sep-2025 NRG Therapeutics Announces Oversubscribed £50m ($67m) Series B Financing to Deliver Clinical Data in Parkinson’s and Proof of Concept in ALS/MND NRG Therapeutics